Adcytherix

Drug Discovery · Marseille, France · Founded 2024 · Privately Held (backing)

Developer of an antibody-drug conjugate platform designed to address resistance and improve safety in cancer therapy through novel payload innovation. Adcytherix is based in Marseille, France and was founded in 2024. It was valued at $213 million at its early-stage round in Jul 2025, the last priced event on record. It has raised $161 million across 2 recorded rounds; the latest was a $126 million Series A in Jul 2025.

PMV mark · valuation
$213.3M
Oct 2026
Priced at
its early-stage round
Jul 2025
Total raised
$160.8M
Last round
Early Stage VC (Series A)
Jul 2025
How much has Adcytherix raised?
$160.8Macross 2 recorded rounds · Jun 2024 – Jul 2025

Most recently, Adcytherix raised $126.3M in its Early Stage VC (Series A) (Jul 2025).

Free account
More of Adcytherix with a free account
  • ·The complete investor list: 13 names
  • ·Watch Adcytherix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Adcytherix round by round

2 rounds
Jul 2025Early Stage VC (Series A)$126.3M▮
+ 1 more investors · free account
Jun 2024Seed Round$38.0M▮
+ 1 more investors · free account

How much has Adcytherix raised?

Adcytherix has raised $161 million across 2 recorded rounds since 2024. The largest was a $38 million seed round in Jun 2024; the most recent was a $126 million Series A in Jul 2025.

Adcytherix investors

13 investors are on record for Adcytherix, including Bpifrance, RA Capital Management, Kinled Holding and European Investment Bank. The Series A in Jul 2025 drew 9 investors.

For fundraisers
Raising for a company like Adcytherix?

13 investors have backed Adcytherix — start your target list with the firms already writing checks in drug discovery.

See all 13 investors →

Frequently asked about Adcytherix

How much has Adcytherix raised?
Adcytherix has raised $160.8M in total across 2 recorded funding rounds.
When was Adcytherix's last funding round?
Adcytherix's most recent recorded round was Early Stage VC (Series A) in Jul 2025, raising $126.3M.